Correlation Between Zentalis PharmaceuticalsL and Siriuspoint

Can any of the company-specific risk be diversified away by investing in both Zentalis PharmaceuticalsL and Siriuspoint at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis PharmaceuticalsL and Siriuspoint into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zentalis PharmaceuticalsLlc and Siriuspoint, you can compare the effects of market volatilities on Zentalis PharmaceuticalsL and Siriuspoint and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis PharmaceuticalsL with a short position of Siriuspoint. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis PharmaceuticalsL and Siriuspoint.

Diversification Opportunities for Zentalis PharmaceuticalsL and Siriuspoint

0.5

Correlation Coefficient

Zentalis PharmaceuticalsL  Siriuspoint

Very weak diversification

The 3 months correlation between Zentalis and Siriuspoint is 0.5. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis PharmaceuticalsLlc and Siriuspoint in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Siriuspoint and Zentalis PharmaceuticalsL is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis PharmaceuticalsLlc are associated (or correlated) with Siriuspoint. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Siriuspoint has no effect on the direction of Zentalis PharmaceuticalsL i.e., Zentalis PharmaceuticalsL and Siriuspoint go up and down completely randomly.

Pair Corralation between Zentalis PharmaceuticalsL and Siriuspoint

Given the investment horizon of 90 days Zentalis PharmaceuticalsLlc is expected to generate 3.09 times more return on investment than Siriuspoint. However, Zentalis PharmaceuticalsL is 3.09 times more volatile than Siriuspoint. It trades about -0.03 of its potential returns per unit of risk. Siriuspoint is currently generating about -0.13 per unit of risk. If you would invest  1,370  in Zentalis PharmaceuticalsLlc on January 20, 2024 and sell it today you would lose (74.00) from holding Zentalis PharmaceuticalsLlc or give up 5.4% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Zentalis PharmaceuticalsLlc  vs.  Siriuspoint

Zentalis PharmaceuticalsL

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Zentalis PharmaceuticalsLlc has generated negative risk-adjusted returns adding no value to investors with long positions. Despite quite persistent basic indicators, Zentalis PharmaceuticalsL is not utilizing all of its potentials. The current stock price mess, may contribute to short-term losses for the institutional investors.

Siriuspoint

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Siriuspoint are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, Siriuspoint is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Zentalis PharmaceuticalsL and Siriuspoint

The main advantage of trading using opposite Zentalis PharmaceuticalsL and Siriuspoint positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis PharmaceuticalsL position performs unexpectedly, Siriuspoint can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Siriuspoint will offset losses from the drop in Siriuspoint's long position.

The idea behind Zentalis PharmaceuticalsLlc and Siriuspoint pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Holdings module to check your current holdings and cash postion to detemine if your portfolio needs rebalancing.